Blood cancer startup targets treatment personalization

Matt De Silva was working at Peter Thiel ’s hedge fund, Clarium Capital, when he learned his father had three rare brain tumors. That discovery led De Silva to a deep dive into personalized cancer drug recommendations — and ultimately toward founding Notable Labs. The Foster City-based company pairs artificial intelligence software wi th flow cytometry lab instruments to figure out which treatment, or combination of drugs, will be the most effective for different types of cancers. Notable is focused…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news